Picture of Proteome Sciences logo

PRM Proteome Sciences Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Proteome Sciences, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.0360.2450.0721.32-2.44
Depreciation
Non-Cash Items0.4180.3120.8820.9991.41
Other Non-Cash Items
Changes in Working Capital-0.4510.861-0.374-0.290.429
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities0.021.580.7932.14-0.481
Capital Expenditures-0.058-0.013-0.204-0.319-0.237
Purchase of Fixed Assets
Other Investing Cash Flow Items00-0.187
Other Investing Cash Flow
Cash from Investing Activities-0.058-0.013-0.204-0.319-0.424
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.058-0.146-0.4-0.209-1.06
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.1591.410.1771.61-1.97